Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Outpatient Treatment of Confirmed COVID-19 (Version 2)

Publication Date: September 19, 2023

Last Updated: September 19, 2023

Practice Points

Consider molnupiravir to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a high risk for progressing to severe disease.

Outpatient Treatment of Confirmed COVID-19 (Version 2)

Practice Points

Overview

Title

Authoring Organization